SEARCH

SEARCH BY CITATION

References

  • Aster, R.H. & Enright, S.E. (1969) A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. Journal of Clinical Investigation, 48, 11991210.
  • Auditore, J.V. & Hartmann, R.C. (1959) Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect. American Journal of Medicine, 27, 401410.
  • Beck, W.S. & Valentine, W.N. (1951) Biochemical studies on leucocytes. II. Phosphatase activity in chronic lymphatic leukemia, acute leukemia, and miscellaneous hematologic conditions. Journal of Laboratory and Clinical Medicine, 38, 245253.
  • Blum, S.F., Sullivan, J.M. & Gardner, F.H. (1967) The exacerbation of hemolysis in paroxysmal nocturnal hemoglobinuria by strenuous exercise. Blood, 30, 513517.
  • Chua, C., Hoffmann, E.M., Adams, J.P. & Rosse, W.F. (1980) Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria. Blood, 55, 772776.
  • Crosby, W.H. (1951) Paroxysmal nocturnal hemoglobinuria. A classic description by Paul Strübing in 1882 and a bibliography of the disease. Blood, 6, 270284.
  • Crosby, W.H. (1953a) Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms. Blood, 8, 769812.
  • Crosby, W.H. (1953b) Paroxysmal nocturnal hemoglobinuria: plasma factors of the hemolytic system. Blood, 8, 444458.
  • Dacie, J.V. (1949) Diagnosis and mechanism of hemolysis in chronic hemolytic anemia with nocturnal hemoglobinuria. Blood, 4, 11831195.
  • Dacie, J.V. (1963) Paroxysmal nocturnal haemoglobinuria. Proceedings of the Royal Society of Medicine, 56, 587596.
  • Dacie, J.V. & Gilpin, A. (1944) Refractory anaemia (Fanconi type): Incidence in three members of one family with in one case a relationship to chronic haemolytic anaemia with nocturnal haemoglobinuria (Marchiafava-Micheli disease or ‘nocturnal haemoglobinuria’). Archives of Diseases of Childhood, 19, 155162.
  • Dacie, J.V. & Lewis, S.M. (1961) Paroxysmal nocturnal haemoglobinuria: variation in clinical severity and association with bone marrow hypoplasia. British Journal of Haematology, 7, 442457.
  • Dacie, J.V. & Lewis, S.M. (1972) Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Series Haematologica, 5, 323.
  • Davitz, M.A., Low, M.G. & Nussenzweig, V. (1986) Release of decay-accelerating factor from the cell membrane by phosphatidylinositol-specific phospholipase C. Journal of Experimental Medicine, 163, 11501161.
  • Endo, M., Ware, R.E., Vreeke, T.M., Singh, S.P., Howard, T.A., Tomita, A., Holguin, M.H. & Parker, C.J. (1996) Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood, 87, 25462557.
  • Fearon, D.T. (1979) Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proceedings of the National Academy of Sciences of the United States of America, 76, 58675871.
  • Fearon, D.T. (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte and monocytes. Journal of Experimental Medicine, 152, 2030.
  • Gull, W.W. (1866) A case of intermittent haematinuria, with remarks. Guy's Hospital Reports, 12, 381392.
  • Ham, T.H. (1937) Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. A study of the mechanism of hemolysis in relation to acid-base equilibrium. New England Journal of Medicine, 217, 915917.
  • Ham, T.H. (1939) Studies on destruction of red blood cells. I. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: an investigation of the mechanism of hemolysis, with observations of five cases. Archives of Internal Medicine, 64, 12711305.
  • Ham, T.H. & Dingle, J.H. (1939) Studies on destruction of red blood cells. II. Chronic hemolytic anemia and paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement. Journal of Clinical Investigation, 18, 657672.
  • Hänsch, G.M., Schonermark, S. & Roelcke, D. (1987) Paroxysmal nocturnal haemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9. Journal of Clinical Investigation, 80, 712.
  • Harris, J.W., Jordan, W.S., Pillemer, L. & Desforges, J.F. (1951) The enzymatic nature of the factor in normal serum which hemolyses the erythrocytes of paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 30, 646 (Abstract).
  • Hijmans van den Bergh, A.A. (1911) Ictère hémolytique avec crises hémoglobinuriques. Fragilité globulaire. Revue Medecine, 31, 6369.
  • Hinz, Jr, C.F., Jordan, Jr, W.S. & Pillemer, L. (1956) The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 35, 453457.
  • Hoffmann, E., Cheng, W., Tomeu, E. & Renk, C. (1974) Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition. Journal of Immunology, 113, 15011509.
  • Hoffmann, E.M. (1969a) Inhibition of complement by a substrate isolated from human erythrocytes. I. Extraction from human erythrocyte stomata. Immunochemistry, 6, 391403.
  • Hoffmann, E.M. (1969b) Inhibition of complement by a substrate isolated from human erythrocytes. II. Studies on the site and mechanism of action. Immunochemistry, 6, 405419.
  • Holguin, M.H., Fredrick, L.R., Bernshaw, N.J. & Parker, C.J. (1989a) Isolation and characterization of a protein from normal erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 84, 717.
  • Holguin, M.H., Wilcox, L.A., Bernshaw, N.J., Rosse, W.F. & Parker, C.J. (1989b) Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuira. Journal of Clinical Investigation, 84, 13871394.
  • Hyman, R. (1980) Evidence for a genetic basis for the class A Thy-1 defect. Immunogenetics, 10, 261271.
  • Hyman, R. (1985) Cell-surface-antigen mutants of haematopoietic cells: tools to study differentiation, biosynthesis and function. Biochemistry Journal, 225, 2740.
  • Hyman, R. (1988) Somatic genetic analysis of the expression of cell surface molecules. Trends in Genetics, 4, 58.
  • Kolata, G. (1985) Novel protein/membrane attachment. Science, 229, 850.
  • Kunstling, T.R. & Rosse, W.F. (1969) Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH) – a comparison of the complement-sensitive and -insensitive populations. Blood, 33, 607616.
  • Logue, G.L., Rosse, W.F. & Adams, J.P. (1973) Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 52, 11291137.
  • Low, M.G. & Finean, J.B. (1977) Non-lytic release of acetylcholinesterase from erythrocytes by a phosphatidylinositols specific phospholipase C. FEBS Letter, 82, 143146.
  • Low, M.G. & Zilversmit, D.B. (1980) Role of phosphatidylinositol in attachment of alkaline phosphatase to membranes. Biochemistry, 19, 39133918.
  • Luzzatto, L. & Nafa, K. (2000) Genetic of PNH, chapter 2. In: PNH and GPI-Linked Proteins (ed. by N.S.Young & J.Moss), pp. 2147. Academic Press, San Diego.
  • Marchiafava, E. & Nazari, A. (1911) Nuovo conttributo allo studio degli itteri cronici emolitici. Il Policlinico. Sezion Medica, 18, 241248.
  • Medof, M.E., Gottlieb, A., Kinoshita, T., Hall, S., Silber, R., Nussenzweig, V. & Rosse, W.F. (1987) Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. Journal of Clinical Investigation, 80, 165174.
  • Miyata, T., Takeda, J., Iida, J., Yamada, N., Inoue, N., Takahashi, M., Maeda, K., Kitani, T. & Kinoshita, T. (1993) The cloning of PIG-A, a component in the early step in GPI-anchor synthesis. Science, 259, 13181320.
  • Nicholson-Weller, A., Burge, J., Fearon, D.T., Weller, P.F. & Austen, K.F. (1982) Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. Journal of Immunology, 129, 184189.
  • Nicholson-Weller, A., March, J.P., Rosenfeld, S.I. & Austen, K.F. (1983) Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proceedings of the National Academy of Sciences of the United States of America, 80, 50665070.
  • Oni, S.B., Osunkoya, B.O. & Luzzatto, L. (1970) Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood, 36, 145152.
  • Opferkuch, W., Loos, M. & Borsos, T. (1971) Isolation and characterization of a factor from human and guinea pig serum that accelerates the decay of the SAC142. Journal of Immunology, 107, 2126.
  • Packman, C.H., Rosenfeld, S.I., Jenkins, Jr, D.E., Thiem, P.A. & Leddy, J.P. (1979) Complement lysis of human erythrocytes. Differing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. Journal of Clinical Investigation, 64, 428433.
  • Pangburn, M.K., Schreiber, R.D. & Müller-Eberhard, H.J. (1983) Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proceedings of the National Academy of Sciences of the United States of America, 80, 54305434.
  • Parker, C.J. (1996) Molecular basis of paroxysmal nocturnal hemoglobinuria. Stem Cells, 14, 396411.
  • Parker, C.J. (2000) Hemolysis in PNH, chapter 3. In: PNH and GPI-Linked Proteins (ed. by N.S.Young & J.Moss), pp. 49100. Academic Press, San Diego.
  • Parker, C.J. & Lee, G.R. (1998) Paroxysmal nocturnal hemoglobinuria, chapter 47. In: Wintrobe's Clinical Hematology (ed. by G.R.Lee, J.Foerster, J.Lukens, F.Paraskevas, J.P.Greer & G.M.Rodgers), pp. 12641288. Williams & Wilkins, Philadelphia,.
  • Parker, C.J., Baker, P.J. & Rosse, W.F. (1982) Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 69, 337346.
  • Parker, C.J., Soldato, C.M. & Rosse, W.F. (1984a) Abnormality of glycophorin-α on paroxysmal nocturnal hemoglobinuria erythrocytes. Journal of Clinical Investigation, 73, 11301143.
  • Parker, C.J., Soldato, C.M. & Telen, M.J. (1984b) Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease. Journal of Clincal Investigation, 74, 10501062.
  • Parker, C.J., Wiedmer, T., Sims, P.J. & Rosse, W.F. (1985) Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes. Journal of Clinical Investigation, 75, 20742084.
  • Peytremann, R., Rhodes, R.S. & Hartmann, R.C. (1972) Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) with particular reference to progressive, diffuse hepatic venous thrombosis. Series Haematologica, 5, 115136.
  • Pillemer, L., Blum, L., Pensky, J. & Lepow, I.H. (1953a) The requirement for magnesium ions in the inactivation of the third component of human complement (C′3) by insoluble residues of yeast cells (zymosan). Journal of Immunology, 71, 331338.
  • Pillemer, L., Lepow, I.H. & Blum, I. (1953b) The requirement for a hydrazine-sensitive serum factor and heat-labile factors in the inactivation of human C′3 by zymosan. Journal of Immunology., 71, 339345.
  • Pillemer, L., Blum, L., Lepow, I.H., Ross, O.A., Todd, E.W. & Wardlaw, A.C. (1954) The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science, 120, 279285.
  • Roberts, W.N., Wilson, J.G., Wong, W., Jenkins, Jr, D.E., Fearon, D.T., Austen, K.F. & Nicholson-Weller, A. (1985) Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria. Journal of Immunology, 134, 512517.
  • Ross, G.D. (1986) Introduction and history of complement research, chapter 1. In: Immunobiology of the Complement System (ed. by G.D.Ross), pp. 119. Academic Press, San Diego.
  • Ross, G.D., Yount, W.J., Walport, M.J., Winfield, J.B., Parker, C.J., Fuller, C.R., Taylor, R.P., Myones, B.L. & Lachmann, P.J. (1985) Disease-associated loss of erythrocyte complement receptors (CR1, C3b-receptors) inpatients with systemic lupus and other diseases involving autoantibodies and/or complement activation. Journal of Immunology, 135, 20052012.
  • Rosse, W.F. (1973) Variations in the red cells of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 24, 327342.
  • Rosse, W.F. (2000) A brief history of PNH, chapter 1. In: PNH and GPI-Linked Proteins (ed. by N.S.Young & J.Moss), pp. 120. Academic Press, San Diego.
  • Rosse, W.F. & Dacie, J.V. (1966) Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. Journal of Clinical Investigation, 45, 736748.
  • Rosse, W.F., Adams, J.P. & Thorpe, A.M. (1974) The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis. British Journal of Haematology, 28, 181190.
  • Rouault, T.A., Rosse, W.F., Bell, S. & Shelburne, J. (1978) Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells. Blood, 51, 325330.
  • Schönermark, S., Rauterberg, E.W., Shin, M.L., Löke, S., Roelcke, D. & Hänsch, G.M. (1986) Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. Journal of Immunology, 136, 17721776.
  • Shin, M.L., Hänsch, G., Hu, V.W. & Nicholson-Weller, A. (1986) Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9. Journal of Immunology, 136, 17771782.
  • Sloand, E.M. & Young, N.S. (2000) Thrombotic complications in PNH, chapter 4. In: PNH and GPI-Linked Proteins (ed. by N.S.Young & J.Moss), pp. 101112. Academic Press, San Diego.
  • Stern, M. & Rosse, W.F. (1979) Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria. Blood, 53, 928934.
  • Strübing, P. (1882) Paroxysmale Hämoglobinurie. Deutsche Medicinische Wochenschrift., 8, 1721.
  • Takahashi, M., Takeda, J., Hirse, S., Hyman, R., Inoue, N., Miyata, T., Ueda, E., Kitani, T., Medof, M.E. & Kinoshita, T. (1993) Deficient biosynthesis of N-acetylglucosaminyl-phosphatidyl-inositol, and early intermediate of GPI anchor biosynthesis in cell lines established from patients with paroxysmal nocturnal haemoglobinuria. Journal of Experimental Medicine, 177, 517521.
  • Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T. & Kinoshita, T. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal haemoglobinuria. Cell, 73, 703711.
  • Yamashina, M., Ueda, D., Kinoshita, T., Takami, T., Ojima, A., Ono, H., Tanaka, H., Kondo, N., Orii, T., Okada, N., Okada, H., Inoue, K. & Kitani, T. (1990) Inherited complete deficiency of 20 kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 323, 11851189.
  • Zalman, L.S., Wood, L.M. & Müller-Eberhard, H.J. (1986) Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proceedings of the National Academy of Sciences of the United States of America, 83, 69756979.
  • Zalman, L.S., Wood, L.M., Frank, M.M. & Müller-Eberhard, H.J. (1987) Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria. Journal of Experimental Medicine, 165, 572577.